Paget's disease in New Zealand: Is it changing?

Bone

Volumn 24, Issue 5 SUPPL., 1999, Pages 7S-9S

  Cundy, T ^a   Wattie, D ^a   Busch, S ^a   Rutland, M ^a   Ibbertson, H K ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE SCINTISCANNING; CLINICAL TRIAL; DEATH CERTIFICATE; DISEASE SEVERITY; ETHNIC DIFFERENCE; HUMAN; MAJOR CLINICAL STUDY; NEW ZEALAND; PAGET BONE DISEASE;

EID: 0032929643     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00024-1     Document Type: Article

References (8)

1. Barker D.J.P. The epidemiology of Paget's disease. Metab Bone Dis Relat Res. 3:1981;231-234.
2. Coutris G., Cayla J., Rondier J., et al. Analyse des perburbations des voies principales du metabolisme calcique dans la maladie de Paget. Rev Rhum Mal Osteoartic. 42:1975;757-759.
3. Cundy T., McAnulty K., Wattie D., et al. Evidence for secular change in Paget's disease. Bone. 20:1997;69-71.
4. Dodd G., Ibbertson H.K., Fraser T.R.C., et al. Radiologic assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD. Br J Radiol. 60:1987;849-860.
5. Fraser T.R.C., Ibbertson H.K., Holdaway I.M., et al. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxy-propylidene-1, 1-bisphosphonate); a comparison with combined calcitonin and EHDP (1-hydroxy-ethylidene-1, 1-bisphosphonate). Aust NZ J Med. 14:1984;811-818.
6. Gardner M.J., Barker D.J.P. Mortality from malignant tumours of bone and Paget's disease in the United States and in England and Wales. Int J Epidemiol. 7:1978;121-130.
7. Kanis J.A. Pathophysiology and Treatment of Paget's Disease of Bone. 1991;81 Martin Dunitz, London.
8. Paget J. Cases of osteitis deformans. Medico-Chir Trans. 65:1882;225-236.